Cannabis-based medicinal products (CBMPs) have shown early promise for refractory childhood epilepsy, but positive media attention, as well as pressure
Continue reading »
mypharmacynews.com
Home »
Cannabis-based medicinal products (CBMPs) have shown early promise for refractory childhood epilepsy, but positive media attention, as well as pressure
Continue reading »Epilepsy surgery may be associated with improvements to overall brain health, a study led by University of Liverpool researchers has
Continue reading »(Reuters Health) – Infants with neonatal opioid withdrawal syndrome (NOWS) may have shorter hospital stays and spend less time on
Continue reading »The US Food and Drug Administration (FDA) has cleared a new over-the-counter device designed to protect children aged 13 years
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TIVICAY 10 mg, 25 mg and 50
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. GABITRIL® VERSION 1.0 Tiagabine hydrochloride monohydrate Consumer
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. RIXADONE Risperidone Oral solution 1mg/mL Consumer Medicine
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MARVELON® 28 (mar-ve-lon) Ethinylestradiol and Desogestrel Consumer
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CHEMMART QUETIAPINE TABLETS Quetiapine fumarate Consumer Medicine
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TRIUMEQ Film-coated tablets 50 mg dolutegravir (as
Continue reading »